Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
7.72
Dollar change
-0.41
Percentage change
-5.04
%
IndexRUT P/E- EPS (ttm)-2.06 Insider Own1.22% Shs Outstand81.77M Perf Week-14.22%
Market Cap631.57M Forward P/E- EPS next Y-2.73 Insider Trans-9.03% Shs Float80.82M Perf Month-7.10%
Income-153.22M PEG- EPS next Q-0.63 Inst Own73.22% Short Float16.73% Perf Quarter-28.78%
Sales78.12M P/S8.08 EPS this Y-26.46% Inst Trans2.34% Short Ratio7.21 Perf Half Y-7.99%
Book/sh4.27 P/B1.81 EPS next Y-6.82% ROA-30.24% Short Interest13.52M Perf Year-9.07%
Cash/sh3.95 P/C1.95 EPS next 5Y1.70% ROE-43.17% 52W Range6.08 - 11.91 Perf YTD-23.79%
Dividend Est.- P/FCF- EPS past 5Y2.88% ROI-41.03% 52W High-35.18% Beta2.05
Dividend TTM- Quick Ratio5.39 Sales past 5Y101.57% Gross Margin92.24% 52W Low26.98% ATR (14)0.62
Dividend Ex-Date- Current Ratio5.39 EPS Y/Y TTM35.88% Oper. Margin-216.56% RSI (14)40.87 Volatility5.13% 7.44%
Employees265 Debt/Eq0.10 Sales Y/Y TTM296.34% Profit Margin-196.13% Recom2.33 Target Price15.40
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q73.84% Payout- Rel Volume1.25 Prev Close8.13
Sales Surprise1523.91% EPS Surprise61.28% Sales Q/Q818.74% EarningsFeb 28 BMO Avg Volume1.88M Price7.72
SMA20-12.80% SMA50-7.94% SMA200-10.94% Trades Volume2,658,315 Change-5.04%
Date Action Analyst Rating Change Price Target Change
Oct-24-23Upgrade Citigroup Neutral → Buy $11
Oct-18-23Upgrade JP Morgan Underweight → Neutral $8
Oct-17-23Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-29-23Upgrade Stifel Hold → Buy $9 → $17
Jun-12-23Upgrade Raymond James Mkt Perform → Outperform $17
Feb-01-23Initiated Cantor Fitzgerald Overweight $15
Dec-13-22Initiated Citigroup Neutral $11
Dec-06-22Resumed Credit Suisse Neutral $13
Nov-18-22Downgrade Oppenheimer Outperform → Perform $28 → $12
Nov-18-22Downgrade Credit Suisse Outperform → Neutral $25 → $13
Mar-07-24 03:31AM
Mar-05-24 11:52PM
Mar-04-24 10:30AM
Mar-02-24 09:49PM
Feb-29-24 11:26AM
08:42AM Loading…
08:42AM
Feb-28-24 11:15PM
08:10AM
07:35AM
07:08AM
07:00AM
Feb-21-24 07:00AM
Feb-19-24 09:55AM
Feb-10-24 05:09PM
Feb-06-24 12:00PM
09:00AM Loading…
Jan-31-24 09:00AM
Jan-28-24 08:45AM
Jan-21-24 09:37AM
Jan-17-24 12:04PM
Jan-15-24 05:19AM
Jan-11-24 04:38PM
Jan-08-24 08:15AM
07:45AM
Jan-03-24 07:00AM
Jan-02-24 10:15AM
Dec-23-23 08:02AM
Dec-14-23 08:32AM
06:30AM
Dec-13-23 05:12PM
04:06PM
12:30PM Loading…
12:30PM
09:00AM
Dec-11-23 01:22PM
12:00PM
Dec-10-23 11:59AM
Dec-05-23 07:00AM
Nov-29-23 02:28PM
Nov-22-23 06:30AM
Nov-20-23 05:43PM
05:36AM
Nov-16-23 03:25PM
Nov-09-23 03:37PM
Nov-06-23 09:00AM
Nov-05-23 05:51PM
Nov-03-23 08:45AM
08:34AM
07:17AM
07:00AM
Nov-02-23 09:12AM
Oct-30-23 03:46PM
Oct-27-23 07:00AM
Oct-24-23 09:51AM
01:53AM
Oct-18-23 11:05AM
09:52AM
09:30AM
Oct-17-23 11:47AM
Oct-16-23 08:00AM
Oct-07-23 10:07AM
Oct-05-23 10:07AM
Oct-02-23 10:00AM
Sep-29-23 11:21AM
Sep-28-23 06:27AM
Sep-25-23 04:30PM
09:00AM
Sep-23-23 08:45AM
Sep-08-23 05:03AM
Sep-07-23 11:30AM
Sep-01-23 11:31AM
Aug-30-23 09:00AM
Aug-28-23 07:00AM
Aug-23-23 08:25AM
Aug-04-23 12:38PM
Aug-03-23 11:45AM
Aug-02-23 08:25AM
07:13AM
07:00AM
Jul-31-23 07:02AM
Jul-27-23 09:00AM
06:29AM
Jul-26-23 07:00AM
Jul-25-23 08:00AM
Jul-24-23 07:00AM
Jun-29-23 09:53AM
Jun-28-23 10:15AM
Jun-20-23 10:23AM
Jun-15-23 10:00AM
Jun-14-23 10:06PM
04:05PM
11:40AM
06:42AM
Jun-12-23 10:00AM
Jun-09-23 01:29PM
03:00AM
Jun-08-23 11:30AM
Jun-06-23 08:00AM
May-22-23 05:38PM
May-18-23 04:30PM
May-16-23 04:30PM
May-11-23 10:32AM
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Neill Gilmore NeilCEOMar 05 '24Sale9.4277,824732,884327,470Mar 05 08:00 PM
Mei BaisongSVP, CHIEF MEDICAL OFFICERMar 04 '24Sale9.4220,327191,425141,543Mar 05 07:54 PM
Eaton BruceEVP, CBO AND CTODec 05 '23Sale10.901031,12274,791Dec 07 04:30 PM
Eaton BruceEVP, CBO AND CTONov 14 '23Sale8.216955,70674,894Nov 16 04:30 PM
Eaton BruceEVP, CBO AND CTONov 07 '23Sale8.401391,16875,589Nov 09 04:31 PM
Eaton BruceEVP, CBO AND CTOSep 06 '23Sale8.8210390875,728Sep 07 04:59 PM
Eaton BruceEVP, CBO AND CTOAug 11 '23Sale8.597026,03375,831Aug 15 04:30 PM
Eaton BruceEVP, CBO AND CTOAug 08 '23Sale8.391411,18376,533Aug 10 04:30 PM
Mei BaisongSVP, CHIEF MEDICAL OFFICERJul 19 '23Sale8.804,31737,99072,055Jul 21 04:30 PM
O'Neill Gilmore NeilCEOJun 05 '23Sale9.506,48661,638130,169Jun 07 04:30 PM
Eaton BruceEVP, CBO AND CTOJun 05 '23Sale9.5010599876,674Jun 07 04:30 PM
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICERMay 11 '23Sale9.879499,369106,610May 15 04:30 PM
Eaton BruceEVP, CBO AND CTOMay 11 '23Sale9.876686,59476,779May 15 04:30 PM
Eaton BruceEVP, CBO AND CTOMay 09 '23Sale9.511351,28477,447May 11 04:30 PM